In case you haven't had enough artificial intelligence, the US Food and Drug Administration is now outsourcing its oversight duties to a large language model (LLM.) In an article published in the Journal of the American Medical Association (JAMA), FDA bureaucrats Marty Makary and Vinay Prasad (the latter of whom is a noted critic of COVID mask mandates and vaccine boosters) laid out a five-point list of priorities that the federal agency is hoping to tackle. Among them is "unleashing AI," a plan to use AI to "radically increase efficiency in the review process." This includes reviewing documents, drug applications […]